210
Participants
Start Date
May 1, 2009
Primary Completion Date
July 1, 2014
Study Completion Date
July 1, 2014
Blood sampling
Blood sampling at Years 11, 12, 13, 14, 15 and at the time of challenge dose administration and one month after challenge dose administration.
Additional challenge dose
If a subject became seronegative for anti-HAV antibodies (\< 15 mIU/mL) or if anti-HBs antibody concentrations decreased below 10 mIU/mL during the long-term follow-up, immune memory against the antigen was evaluated by administering a challenge dose of the appropriate antigen (vaccine) 6 to 12 months after the Year 15 follow-up time-point.
GSK Investigational Site, Brussels
GSK Investigational Site, Hradec Králové
Lead Sponsor
GlaxoSmithKline
INDUSTRY